Home›Companies›Biotech & Pharma›Endo

Endo, Inc.

Updated Oct 27, 2026·Latest SEC filing May 6, 2024·Suggest an edit

About Endo

Endo is a private company based in Malvern, Pennsylvania, incorporated in 2023 in Delaware. It has reported $170,574,224 raised in one offering on Form D since March 2024. Its chief executive is Blaise Coleman.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 21, 2024Mar 21, 2024amended May 6, 2024$170,574,224fully sold404$422KEquityRule 506(b)Form D/A ↗1 earlier filing

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Endo's Form D filed May 6, 2024.

SH
Scott Hirsch
Director
PE
Paul Efron
Director
PH
MY
PB
Patrick Barry
Executive Vice President; President, Global Commercial Operations
BC
Blaise Coleman
President; Chief Executive Officer and director
MM
Matthew Maletta
Executive Vice President; Chief Legal Officer; Secretary
SL
FR
Frank Raciti
Vice President; Controller; Chief Accounting Officer
MB
Mark Bradley
Executive Vice President; Chief Financial Officer and director
AP

Sources

  1. SECEndo, Inc. Form D, filed Mar 21, 2024
  2. SECEndo, Inc. filing history